Evaluation of Serum CA15-3 Determination With CEA and TPA in the Post-Operative Follow-Up of Breast Cancer Patients

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.1991.260
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Clinical Value of Serum S100a8/A9 and CA15-3 in the Diagnosis of Breast Cancer

2019English

Serum Thyroglobulin Determination in the Follow-Up of Patients With Differentiated Thyroid Carcinoma

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
1998English

Evaluation of Serum Levels of CEA and CA19-9 as Parameters of Following Up for Patients With Gastric Cancer.

Japanese Journal of Gastroenterological Surgery
SurgeryGastroenterology
1999English

Long-Term Follow-Up of Breast Cancer Survivors With Post-Mastectomy Pain Syndrome

British Journal of Cancer
Cancer ResearchOncology
2005English

Intensive Risk-Adjusted Follow-Up With the CEA, TPA, CA19.9, and CA72.4 Tumor Marker Panel and Abdominal Ultrasonography to Diagnose Operable Colorectal Cancer Recurrences

Archives of Surgery
2010English

Evaluation of Serum CEA and CA19-9 Levels as Prognostic Factors in Patients With Gastric Cancer

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2000English

Chest X-Ray Survey in the Follow-Up of Breast Cancer Patients

British Journal of Cancer
Cancer ResearchOncology
1989English

The Importance of Symptoms in Breast Cancer Follow-Up

Journal of Case Reports and Images in Obstetrics and Gynecology
2019English

Follow-Up After Breast Cancer

BMJ
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy